Ayala Pharmaceuticals Debt / Equity
Cos'è Debt / Equity di Ayala Pharmaceuticals?
Debt / Equity di Ayala Pharmaceuticals Inc. è 1.07
Qual è la definizione di Debt / Equity?
Il rapporto debito è un rapporto finanziario che indica la proporzione relativa del patrimonio netto e del debito utilizzato per finanziare le attività di una società.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Debt / Equity di aziende nel Health Care settore su NASDAQ rispetto a Ayala Pharmaceuticals
Cosa fa Ayala Pharmaceuticals?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Aziende con debt / equity simili a Ayala Pharmaceuticals
- N R Agarwal Industries ha Debt / Equity di 1.07
- Montrose Environmental ha Debt / Equity di 1.07
- Smruthi Organics ha Debt / Equity di 1.07
- Locality Planning ha Debt / Equity di 1.07
- GR Properties ha Debt / Equity di 1.07
- Genocea Biosciences ha Debt / Equity di 1.07
- Ayala Pharmaceuticals ha Debt / Equity di 1.07
- Finsbury Food Plc ha Debt / Equity di 1.07
- Wockhardt ha Debt / Equity di 1.07
- Compagnie Financière Richemont SA ha Debt / Equity di 1.07
- Tsuruha ha Debt / Equity di 1.07
- RF Industries ha Debt / Equity di 1.07
- Orbit Garant Drilling ha Debt / Equity di 1.07